On 7 May 2012, Presidential Decree Nr. 598 introduced a state-monitored target indicator concerning the share of locally-produced vital and essential drugs. A value of 90% of domestically-produced medicines falling into this particular category shall be reached by 2018.
 
The affected foreign jurisdictions are identified on the basis of the country of origin of the top foreign pharma companies that operate on the Russian market (see Annex 2 of the 6th provided source for more details).